![Spacer](https://webarchive.library.unt.edu/eot2008/20090117233228im_/http://www.fda.gov/cvm/Images/dot_clear.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090117233228im_/http://www.fda.gov/cvm/Images/dot_clear.gif)
Table of Contents
|
![Spacer](https://webarchive.library.unt.edu/eot2008/20090117233228im_/http://www.fda.gov/cvm/Images/dot_clear.gif) |
![Spacer](https://webarchive.library.unt.edu/eot2008/20090117233228im_/http://www.fda.gov/cvm/Images/dot_clear.gif) |
The Veterinary Medicine Advisory Committee (VMAC or the Committee) advises the Commissioner of the Food and Drug Administration (the Commissioner) in discharging their responsibilities as they relate to assuring safe and effective drugs, feeds and feed additives, and devices for animal use, and, as required, any other product for which the Food and Drug Administration has regulatory responsibility. The Committee reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational new animal drugs, feeds, and devices for use in the treatment and prevention of animal diseases and increased animal production, and makes appropriate recommendations to the Commissioner regarding scientific issues and regulatory policies.
EXECUTIVE SECRETARY Aleta Sindelar Center for Veterinary Medicine Food and Drug Administration 7519 Standish Place Rockville, MD 20855 Aleta.Sindelar@fda.hhs.gov
Web Page Updated by hd - November 6, 2007, 5:30 PM ET
|
![Spacer](https://webarchive.library.unt.edu/eot2008/20090117233228im_/http://www.fda.gov/cvm/Images/dot_clear.gif) |